Cusatuzumab CAS No.1864871-20-4
Cusatuzumab CAS No.1864871-20-4
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-1949 | 1mg | 310.00 | + Add to cart |
|
| R-R-1949 | 2mg | 520.00 | + Add to cart |
|
|
|
||||
Product description
Cusatuzumab/CAS No.1864871-20-4 is a human αCD70 monoclonal antibody. Cusatuzumab shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML).
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| Purity | >90% |
| CAS | 1864871-20-4 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Cusatuzumab CAS No.1864871-20-4
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


